Bone Medical completes merger with Revenir

By Melissa Trudinger
Monday, 23 August, 2004

UK biotech company Bone Limited has completed its merger with Perth-based listed property management company Revenir (ASX: REV) after a successful capital raising of $2.5 million closed oversubscribed earlier in the month.

The company, which will be known as Bone Medical, is expected to start trading on August 31, 2004 under the stock symbol BNE.

Giving rotavirus vaccine at birth benefits gut bacteria

Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...

TGA approves donanemab for treatment of early Alzheimer's

The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...

Ultra-processed foods linked to poor health, premature death

Evidence suggests a dose-response relationship between ultra-processed food consumption and...

Content from other channels on our network

Lithium–CO2 battery provides green energy alternative

City of Gosnells renews WALGA sustainability commitment

Next-gen liquid battery for solar energy from rooftops

Smith & Loveless acquires CST Wastewater Solutions

Grid-free solar streetlights light up Darlington Point

CeMAT 2025 incorporates processing, packaging and more

WA Government investing $500 million to unlock industrial areas

Homegrown solar pioneer first to be funded for Solar Sunshot

Researchers show robots how to identify an object's properties through handling

UAE-funded consortium to build a waste‍-‍to‍-‍energy facility in Parkes

Injectable tech for fresh produce could extend shelf life

Manufacturing most impacted by ransomware in Q1 2025

Balancing packaging waste and food waste through data-driven design

Call for comment on thermolysin as a processing aid

No kidding: Australia's goatmeat exports at all-time high